OrbiMed

Founded in New York City in 1989, OrbiMed grew from an investment business focused on healthcare into a global investment firm backing companies across the healthcare industry. The firm invests in organizations working on the discovery and development of biopharmaceutical products, medical technologies, medical devices, diagnostics, drug discovery tools, healthcare information technology, and healthcare services. Its founding premise is that scientific innovation and changing global demographics create important opportunities to improve health.

OrbiMed invests across the company lifecycle and public markets, from seed-stage ventures and start-ups to large publicly traded companies. Its strategies include private equity, public equity, and private credit and royalty financing. The firm says it provides tailored financing solutions and global team resources to help healthcare companies grow. Its professionals bring experience in life sciences, medicine, science, and finance, and its investment activity spans global markets. OrbiMed’s stated aim is to help drive innovation, address unmet medical needs, and improve patient outcomes.